Iovance closes $197.1M public offering of 23M shares at $9.15/share

IOVANCE BIOTHERAPEUTICS, INC.

Closed sale of 23,014,000 shares at $9.15 per share in underwritten offering.
Net proceeds expected to be approximately $197.1M after discounts and expenses.
Offering previously disclosed; closing occurred on February 22, 2024.

item 8.01 item 9.01

IOVANCE BIOTHERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001104659-24-026578

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.